关注
Xiao Kunmin
Xiao Kunmin
Beijing University of Chinese Medicine
在 bucm.edu.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
Chinese herbal medicine for primary liver cancer therapy: perspectives and challenges
K Li, K Xiao, S Zhu, Y Wang, W Wang
Frontiers in Pharmacology 13, 889799, 2022
202022
Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta‐Analysis
K Xiao, K Xiao, K Li, P Xue, S Zhu
Journal of Immunology Research 2021 (1), 5440572, 2021
202021
Potential Molecular Mechanisms of Chaihu‐Shugan‐San in Treatment of Breast Cancer Based on Network Pharmacology
K Xiao, K Li, S Long, C Kong, S Zhu
Evidence‐Based Complementary and Alternative Medicine 2020 (1), 3670309, 2020
182020
Integrated analysis of lncRNA-mediated ceRNA network reveals a prognostic signature for hepatocellular carcinoma
JR Sun, CF Kong, KM Xiao, JL Yang, XK Qu, JH Sun
Frontiers in Genetics 11, 602542, 2020
92020
A systematic review and meta-analysis of randomized controlled trials on treating ulcerative colitis by the integration method of heat-clearing, damp-excreting, spleen …
ZJ Jia, ZH Yang, CX Jia, KM Xiao, YQ Niu, J Chen, SJ Duan, SK Yao, Y Li
World Journal of Traditional Chinese Medicine 6 (1), 74-89, 2020
92020
Unveiling potential mechanisms of Spatholobi Caulis against lung metastasis of malignant tumor by network pharmacology and molecular docking
F Xie, M Wang, Y Su, K Xiao, X Chu, S Long, L Li, X Zhang, P Xue, S Zhu
Evidence‐Based Complementary and Alternative Medicine 2022 (1), 1620539, 2022
62022
Prognostic and immunological value of LTB4R in pan-cancer
S Long, S Ji, K Xiao, P Xue, S Zhu
Mathematical Biosciences and Engineering 18 (6), 9336-9356, 2021
32021
Research progress on the treatment of advanced prostate cancer with Olaparib.
SU Yi-Xin, YU Cheng-Feng, XUE Peng, LI Lin-Lu, X Kun-Min, ...
Neoplasma 68 (6), 2021
22021
Multiple Classes of Antibiotic Use in Infancy and Allergic Disease in Childhood
KM Xiao, SX Liang, Y Liu
JAMA pediatrics 174 (10), 1002-1002, 2020
22020
系统目前无法执行此操作,请稍后再试。
文章 1–9